English Site

Indications

Basically, the CRP reduction can bring a therapeutic benefit in a number of acute and chronic diseases.

PentraSorb® CRP - Potential therapeutic option for:

  • Acute myocardial infarction
  • Stroke
  • Global cerebral ischemia after resuscitation
  • Diseases of the rheumatic form circle
  • Crohn's disease
  • Ulcerative colitis
  • Pancreatitis
  • Postoperative SIRS